Physician profile
Ericka P Stone
NPI 1659562619
$1,089.77
in general payments reported to CMS, 2019-2025
17 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $377 · 2023: $423 · 2024: $100 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $167.14 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $135.62 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Asensus Surgical, INC. | $117.80 | 2023 | Senhance |
| Myriad Women'S Health, INC. | $104.37 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $95.23 | 2022-2025 | Aptima |
| Organon LLC | $93.60 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $78.15 | 2022-2023 | |
| Evofem Biosciences, INC. | $64.97 | 2022 | |
| Astellas Pharma US INC | $52.35 | 2022-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.67 | 2022 | |
| Abbvie INC. | $37.44 | 2022 | |
| Shield Therapeutics INC | $19.93 | 2023 | Accrufer |
| Scynexis, INC. | $18.34 | 2022 | |
| Mylan Pharmaceuticals INC. | $18.28 | 2022 | |
| Avion Pharmaceuticals | $17.03 | 2023 | Balcoltra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $16.64 | 2022 | |
| Pfizer INC. | $15.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ericka Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.